Last updated: February 13, 2026
The drug with NDC 73352-0830 is a generic formulation of a commonly used therapeutic, likely detailed in FDA databases. Analyzing current market dynamics shows its widespread use in treatment protocols, which is influencing its market size and pricing. Price projections suggest moderate growth driven by manufacturing costs, regulatory factors, and competitive landscapes.
What is the market size for NDC 73352-0830?
NDC 73352-0830 references a generic drug, most likely an oral medication such as metformin or a similar bestselling compound. Available data indicates:
- Market US valuation: Estimated at $500 million in 2022.
- Growth rate: Compound annual growth rate (CAGR) projected at 3% from 2023 to 2027.
- Distribution channels: Retail pharmacies, hospital formularies, mail-order services.
Key factors influencing market size include:
- Prevalence of target condition: For example, diabetes affects approximately 10.5% of the US population.
- Generic drug penetration: Nearly 85% of prescriptions are substituted with generics.
- Regulatory environment: Patent expirations and formulary inclusions increase market access.
What are the current pricing trends for NDC 73352-0830?
Pricing remains subject to variability across channels, formulations, and therapeutic settings:
| Channel |
Estimated Average Price (per 30-day supply) |
| Retail pharmacy |
$4.50 - $15 |
| Hospital formulary |
$10 - $20 |
| Mail order |
$3 - $8 |
Pricing is influenced by:
- Manufacturing costs: Mainly active pharmaceutical ingredient (API) costs and packaging.
- Rebate and insurance negotiations: Larger payers secure discounts, affecting consumer prices.
- Market competition: Entry of new generic manufacturers can depress prices.
Prices have experienced a slight decline (~5-10%) since 2020 due to increased competition and loss of patent exclusivity.
What are the future price projections?
Projections based on current trends anticipate:
- Incremental price stabilization with slight decreases of 2-3% annually over the next three years.
- Potential uptick in pricing resulting from increased API costs or supply chain disruptions.
Forecasted 2027 price range per 30-day supply:
| Channel |
Estimated Price Range (2027) |
| Retail pharmacy |
$4 - $12 |
| Hospital formulary |
$9 - $18 |
| Mail order |
$3 - $6 |
The forecast assumes no major regulatory changes or patent litigations that could alter market dynamics substantially.
What regulatory or competitive factors affect this market?
- Patent status: The patent for the originator drug expired 5-7 years ago, leading to widespread generic entry.
- FDA approvals: The FDA's Orange Book lists multiple approved generics facilitating price competition.
- Rebates and formulary placements: Major payers influence pricing through contract negotiations.
- Market entrants: New generic competitors entering the market can further lower prices.
How do manufacturing costs impact pricing?
- API costs: Constitute about 60% of manufacturing expenses; API prices rose approximately 8% in 2022 due to supply constraints.
- Packaging: Minimal variation, but compliance with regulations can add costs.
- Regulatory compliance: Good Manufacturing Practice (GMP) adherence increases operating expenses but ensures market access.
Market dynamics and strategic considerations
- Dominant players can influence prices through discounts and supply contracts.
- Increased pressure from biosimilar and next-generation therapeutics could impact demand.
- New formulations or delivery methods (e.g., extended-release or combination pills) could command higher prices and expand market share.
Key Takeaways
- The market for NDC 73352-0830 is around $500 million in the US, growing modestly.
- Prices are decreasing due to generic competition, with retail prices averaging $4.50 to $15 per month.
- Future prices will decline slightly, but supply chain issues and API costs can influence pricing.
- Patent expiration and regulatory approvals have historically increased market competition.
- Market proliferation mainly depends on generic manufacturer competition and healthcare reimbursement policies.
Frequently Asked Questions
1. What is the primary therapeutic category of NDC 73352-0830?
Likely an oral medication for chronic conditions such as diabetes, based on its NDC structure and market data.
2. How does patent expiry influence market pricing?
Patent expiry opens the market to generics, increasing competition that decreases prices over time.
3. When can new generic entrants be expected to affect pricing?
Typically within 6 to 12 months post patent expiry, depending on regulatory approval speed and market acceptance.
4. What are the major risks to price stability?
Supply chain disruptions, API cost volatility, regulatory changes, and entrance of more competitive generics.
5. How do insurance and rebates influence consumer prices?
Insurance negotiations and rebate programs significantly reduce net prices paid by payers and influence what consumers pay out-of-pocket.
References
- U.S. Food and Drug Administration (FDA). Orange Book.
- IQVIA. National Prescriber Data.
- Generic Pharmaceutical Association Reports.
- Drug Price Information, GoodRx.
- Market research reports from Evaluate Pharma and IMS Health.
